Cytodyn Inc (CYDY)

[moneycrew]

From NGK off another bord- spot on- tick tock

BP would pay their proxy to do their work. BP paying Amarex and / or 13D to do their dirty work. Just like they are behind the shorts campaign, paying the interest on their borrowed shorted shares which drive the stock price down in syncrony with their timed Big Media hit pieces and FDA warning letters? Are the traders who short the stock really the ones bearing the interest on their loans? When they short a stock below $1, they pay interest at about 20% on each share as if it were priced at $1. So if they short 50,000 shares at $0.35, they begin paying 20% interest annually on $50,000, no on $17,500 (35% of $50k) or $10,000 annually. Currently 50,000,000 shares are sold short and applying above pricing, someone is paying about $500k monthly in interest to maintain these shares held short rather than buying them back and returning them to lender. I could see that short traders would be willing to risk holding the shares short if they were not the ones actually paying the interest. So that's why I think BP is paying the interest, (through Big Money, the brokerage houses in cahoots with Big Pharma), on these short trades because no one in their right mind would be willing to take such a risk. Especially not when the company is so quiet. Not when the liver conference is next week. Not when the aggregated safety data could come back as acceptable next week. Not when the Hold may get lifted at any time and not when a partnership may be announced at any moment.